Epstein Secrets

mmunications Amanda Shoch said Ratcliffe's "top priority is our nation's security." Meanwhile, the Washington Times (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Intelligence, wrote to Ratcliffe criti

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

hington Times <https://wvvw.washingtontimes.com/news/2020/oct/8/elissa-slotkin-former- cia-analyst-accuses-dni-johnk (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Intelligence, wrote to Ratcliffe criti

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

munications Amanda Shoch said Ratcliffe's "top priority is our nation's security." Meanwhile, the Washington Times (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Intelligence, wrote to Ratcliffe criti

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

munications Amanda Shoch said Ratcliffe's "top priority is our nation's security." Meanwhile, the Washington Times (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Intelligence, wrote to Ratcliffe criti

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,